Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications
Small · 2026
DOI: 10.1002/smll.74060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, 2026. Verfasst von Chengliang Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, The "Pioneer" and "Leading Goose" R&D Program of Zhejiang.
Abstract (Originalsprache)
Nucleic acid aptamers represent a distinctive class of molecular recognition elements with high binding affinity, excellent chemical stability, and low immunogenicity, making them powerful tools for diverse biomedical applications. Nevertheless, monovalent aptamers are often constrained by limited binding avidity, suboptimal pharmacokinetics, and insufficient biological activation. To address these challenges, multivalent aptamers engineered by assembling multiple units in a well‐defined spatial configuration, have emerged to significantly enhance target engagement. This approach improves affinity, specificity, and functional potency, unlocking novel applications inaccessible to monovalent constructs. This review provides a comprehensive overview of recent advances in multivalent aptamer engineering. First, we outline advancements in systematic evolution of ligands by exponential enrichment (SELEX) strategies enabling the direct evolution of multivalent aptamers through rational library design and target‐guided selection. Subsequently, we discuss various design approaches for constructing multivalent architectures, alongside their advantages and limitations. Finally, we highlight representative applications, including targeted delivery, therapeutic intervention, molecular imaging, and diagnostics, which capitalize on the multivalency effect to achieve superior biological outcomes in next‐generation biomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
- The Key Laboratory of Zhejiang Province For Basic and Clinical Application of Functional Nucleic Acids, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
ORCID-Profile: Xuanrong Sun
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- The "Pioneer" and "Leading Goose" R&D Program of Zhejiang
Zitieren
APA
Liu, C., Tang, Z., Zhu, Y., Sun, X., Xu, L., & Liu, X. (2026). Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications. Small. https://doi.org/10.1002/smll.74060
Vancouver
Liu C, Tang Z, Zhu Y, Sun X, Xu L, Liu X. Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications. Small. 2026. doi:10.1002/smll.74060
BibTeX
@article{Liu2026,
author = {Liu, Chengliang and Tang, Zhijun and Zhu, Yilin and Sun, Xuanrong and Xu, Lujuan and Liu, Xiangsheng},
title = {Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications},
journal = {Small},
year = {2026},
doi = {10.1002/smll.74060}
}
EUVIMED